The cost-effectiveness of prenatal screening for spinal muscular atrophy

Kostova, 2007, Spinal muscular atrophy: classification, diagnosis, management, pathogenesis, and future research directions, J Child Neurol, 22, 926, 10.1177/0883073807305662 2009, ACOG committee opinion no 432, Obstet Gynecol, 133, 1194 Prior, 2008, Carrier screening for spinal muscular atrophy, Genet Med, 10, 840, 10.1097/GIM.0b013e318188d069 Caughey, 2006, Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss, Obstet Gynecol, 108, 612, 10.1097/01.AOG.0000232512.46869.fc Odibo, 2008, Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience, Obstet Gynecol, 111, 589, 10.1097/AOG.0b013e318162eb53 Eddleman, 2006, Pregnancy loss rates after midtrimester amniocentesis, Obstet Gynecol, 108, 1067, 10.1097/01.AOG.0000240135.13594.07 Doyle, 2003, Prenatal cystic fibrosis screening in Mexican Americans: an economic analysis, Am J Obstet Gynecol, 189, 769, 10.1067/S0002-9378(03)00717-8 2003 2009 Siegel, 1996, Recommendation for reporting cost-effectiveness analysis, JAMA, 276, 1339, 10.1001/jama.1996.03540160061034 Harris, 2004, Cost utility of prenatal diagnosis and the risk-based threshold, Lancet, 363, 276, 10.1016/S0140-6736(03)15385-8 Waitzman, 1994, Estimates of the economic costs of birth defects, Inquiry, 31, 188 2009 Wang, 2007, Consensus statement for standard of care in spinal muscular atrophy, J Child Neurol, 22, 1027, 10.1177/0883073807305788 Hardart, 2002, Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes, Pediatrics, 110, e24, 10.1542/peds.110.2.e24 Sevick, 1996, Economic cost of home-based care for ventilator-assisted individuals, Chest, 109, 1597, 10.1378/chest.109.6.1597 Kuppermann, 2000, Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences, Obstet Gynecol, 96, 511, 10.1016/S0029-7844(00)00969-8 Bach, 2003, Spinal muscular atrophy type 1 quality of life, Am J Phys Med Rehabil, 82, 137, 10.1097/00002060-200302000-00009 Owens, 1998, Interpretation of cost-effectiveness analyses, J Gen Intern Med, 13, 716, 10.1046/j.1525-1497.1998.00211.x Gold, 1996 Dosiou, 2008, Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis, Eur J Endocrinol, 158, 841, 10.1530/EJE-07-0882 Vandenbussche, 1999, Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians, Birth, 26, 178, 10.1046/j.1523-536x.1999.00178.x Radhakrishnan, 2008, Economic evaluation of cystic fibrosis screening: a review of the literature, Health Policy, 85, 133, 10.1016/j.healthpol.2007.07.007 Rowley, 1998, Prenatal screening for cystic fibrosis: an economic evaluation, Am J Hum Genet, 63, 1160, 10.1086/302042